Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Annual Meeting of Stockholders of Biosyntech, Inc.


LAVAL, Quebec Laval (pronounced ) is a city and a region in southwestern Quebec, Canada in the Greater Montreal Area. It is located on Île Jésus, across the Rivière des Prairies from Montreal.  -- Mr. Claude LeDuc, President and Chief Executive Officer, announces the Annual Meeting of Stockholders of BioSyntech Inc. (TSX Venture Exchange TSX Venture Exchange

Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors.
 'BSY'), that will be held at the Montreal Marriott Chateau Champlain, 1050 De La Gauchetiere West, Viger Hall, Montreal, Quebec on Thursday, September 23, 2004, 10:00 A.M local time.Members of the press are cordially invited to attend the event and meet with the Company's senior management immediately following the meeting.

BIOSYNTECH INC. (TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
 VENTURE:BSY BSY Busy
BSY British School of Yoga
BSY Bit Sync
BSY Busy Line
)
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 17, 2004
Words:80
Previous Article:Research and Markets: Risk Budgeting: A New Approach to Investing.
Next Article:Research and Markets: The Ubiquitous Landscape of Satellite Services is about to Change.



Related Articles
BIOSYNTECH/BIOMET TO DEVELOP NEW HARD TISSUE HEALING.
BIOSYNTECH REPORTS SUCCESSFUL SAFETY EVALUATION OF BST-GEL.
An Update of BioSyntech Activities.
Annual Meeting of Stockholders of BioSyntech, Inc.
BioSyntech: Letter to Our Shareholders.
Annual Meeting of Stockholders of BioSyntech, Inc.
Media Advisory: Biosyntech's Annual General Shareholders' Meeting and Media Briefing Session.
BioSyntech Files Application for Investigational Testing Authorization 'ITA' for Canadian Multi-Center Clinical Trial for BST-CarGel'R'.
Nicholas Piramal India Limited And Biosyntech, Inc. Announce Signing Of Formal Agreements.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles